• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯噻酮与氢氯噻嗪的比较疗效和安全性-荟萃分析。

Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide-meta-analysis.

机构信息

Science Department, Tchaikapharma High Quality Medicines, Inc, 1 G.M. Dimitrov Blvd, 1172, Sofia, Bulgaria.

Department of Informatics, New Bulgarian University, 21 Montevideo Str, 1618, Sofia, Bulgaria.

出版信息

J Hum Hypertens. 2019 Nov;33(11):766-774. doi: 10.1038/s41371-019-0255-2. Epub 2019 Oct 8.

DOI:10.1038/s41371-019-0255-2
PMID:31595024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6892412/
Abstract

Hypertension is a complex syndrome of multiple hemodynamic, neuroendocrine, and metabolic abnormalities. The goals of treatment in hypertension are to optimally control high blood pressure and to reduce associated cardiovascular morbidity and mortality using the most suitable therapy available. Hydrochlorothiazide (HCTZ) and chlorthalidone (CTLD) are with proven hypertensive effects. The topic of our meta-analysis is to compare the efficacy of HCTZ and CTLD therapy in patient with hypertension. A search of electronic databases PubMed, MEDLINE, Scopus, PsyInfo, eLIBRARY.ru was performed. We chose the random-effects method for the analysis and depicted the results as forest plots. Sensitivity analyses were performed in order to evaluate the degree of significance of each study. Of the 1289 identified sources, only nine trials directly compared HCTZ and CTLD and were included in the meta-analysis. Changes in SBP lead to WMD (95% CI) equal to -3.26 mmHg showing a slight but statistically significant prevalence of CTLD. Results from analyzed studies referring to DBP lead to WMD (95% CI) equal to -2.41 mmHg, which is also statistically significant. During our analysis, we found that there were not enough studies presenting enough data on the effect of CTLD and HCTZ on levels of serum potassium and serum sodium. Our meta-analysis has demonstrated a slight superiority for CTLD regarding blood pressure control. At the same time, the two medications do not show significant differences in their safety profile.

摘要

高血压是一种涉及多种血流动力学、神经内分泌和代谢异常的复杂综合征。高血压治疗的目标是通过使用最合适的治疗方法,最佳地控制高血压,并降低相关的心血管发病率和死亡率。氢氯噻嗪(HCTZ)和氯噻酮(CTLD)已被证明具有降压作用。我们的荟萃分析的主题是比较 HCTZ 和 CTLD 治疗高血压患者的疗效。对电子数据库 PubMed、MEDLINE、Scopus、PsyInfo、eLIBRARY.ru 进行了检索。我们选择了随机效应方法进行分析,并以森林图的形式展示结果。进行了敏感性分析,以评估每项研究的显著性程度。在确定的 1289 个来源中,只有 9 项试验直接比较了 HCTZ 和 CTLD,并被纳入荟萃分析。收缩压的变化导致 WMD(95%CI)等于-3.26mmHg,表明 CTLD 略有但具有统计学意义的优势。关于 DBP 的分析研究结果导致 WMD(95%CI)等于-2.41mmHg,这也具有统计学意义。在我们的分析中,我们发现没有足够的研究提供足够的数据来评估 CTLD 和 HCTZ 对血清钾和血清钠水平的影响。我们的荟萃分析表明,CTLD 在控制血压方面略有优势。同时,这两种药物在安全性方面没有显著差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/b8e8c107194c/41371_2019_255_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/7bf9620066cd/41371_2019_255_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/5978f97fff1c/41371_2019_255_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/3a4ba3bcbe0b/41371_2019_255_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/b8e8c107194c/41371_2019_255_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/7bf9620066cd/41371_2019_255_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/5978f97fff1c/41371_2019_255_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/3a4ba3bcbe0b/41371_2019_255_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/26e6/6892412/b8e8c107194c/41371_2019_255_Fig4_HTML.jpg

相似文献

1
Comparative efficacy and safety of chlorthalidone and hydrochlorothiazide-meta-analysis.氯噻酮与氢氯噻嗪的比较疗效和安全性-荟萃分析。
J Hum Hypertens. 2019 Nov;33(11):766-774. doi: 10.1038/s41371-019-0255-2. Epub 2019 Oct 8.
2
Combining angiotensin receptor blockers with chlorthalidone or hydrochlorothiazide - which is the better alternative? A meta-analysis.联合应用血管紧张素受体阻滞剂与氯噻酮或氢氯噻嗪——哪一种是更好的选择?一项荟萃分析。
Syst Rev. 2020 Aug 24;9(1):195. doi: 10.1186/s13643-020-01457-9.
3
Network meta-analysis of efficacy and safety of chlorthalidone and hydrochlorothiazide in hypertensive patients.氯噻酮与氢氯噻嗪治疗高血压患者的疗效和安全性的网状Meta 分析。
Blood Press Monit. 2021 Apr 1;26(2):160-168. doi: 10.1097/MBP.0000000000000486.
4
Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis.氢氯噻嗪与氯噻酮、吲达帕胺和保钾/氢氯噻嗪利尿剂降低左心室肥厚的比较:系统评价和荟萃分析。
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1507-1515. doi: 10.1111/jch.13386. Epub 2018 Sep 24.
5
Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.噻嗪类利尿剂单药治疗原发性高血压的降压疗效。
Cochrane Database Syst Rev. 2014 May 29;2014(5):CD003824. doi: 10.1002/14651858.CD003824.pub2.
6
Evaluation of the efficacy and safety of a hydrochlorothiazide to chlorthalidone medication change in veterans with hypertension.评估氢氯噻嗪转换为氯噻酮治疗高血压退伍军人的疗效和安全性。
Clin Ther. 2013 Sep;35(9):1423-30. doi: 10.1016/j.clinthera.2013.07.430. Epub 2013 Aug 29.
7
Race-Specific Comparisons of Antihypertensive and Metabolic Effects of Hydrochlorothiazide and Chlorthalidone.氢氯噻嗪和氯噻酮的降压和代谢作用的种族特异性比较。
Am J Med. 2021 Jul;134(7):918-925.e2. doi: 10.1016/j.amjmed.2020.12.015. Epub 2021 Jan 9.
8
Efficacy of chlorthalidone and hydrochlorothiazide in combination with amiloride in multiple doses on blood pressure in patients with primary hypertension: a protocol for a factorial randomized controlled trial.氯噻酮和氢氯噻嗪联合阿米洛利多剂量治疗原发性高血压患者的血压疗效:一项析因随机对照试验方案
Trials. 2019 Dec 16;20(1):736. doi: 10.1186/s13063-019-3909-z.
9
Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure.氢氯噻嗪和氯噻酮对动态血压和诊室血压的降压效果比较
Hypertension. 2006 Mar;47(3):352-8. doi: 10.1161/01.HYP.0000203309.07140.d3. Epub 2006 Jan 23.
10
Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses.氯噻酮与氢氯噻嗪降低心血管事件的比较:系统评价和网络荟萃分析。
Hypertension. 2012 Jun;59(6):1110-7. doi: 10.1161/HYPERTENSIONAHA.112.191106. Epub 2012 Apr 23.

引用本文的文献

1
Effectiveness and safety of chronic diuretic use in older adults: an umbrella review of recently published systematic reviews and meta-analyses of randomized-controlled trials.老年人长期使用利尿剂的有效性和安全性:对近期发表的随机对照试验系统评价和荟萃分析的综合评价
Eur Geriatr Med. 2025 May 25. doi: 10.1007/s41999-025-01229-5.
2
Comparison of Cardiovascular Outcomes Between Chlorthalidone and Hydrochlorothiazide in Hypertensive Patients.氯噻酮与氢氯噻嗪治疗高血压患者心血管结局的比较
J Clin Hypertens (Greenwich). 2025 Feb;27(2):e70000. doi: 10.1111/jch.70000.
3
Identifying pseudo-resistant hypertension and optimizing diuretic therapy for confirmed resistant cases in primary care.

本文引用的文献

1
Comparison of thiazide-like diuretics versus thiazide-type diuretics: a meta-analysis.噻嗪样利尿剂与噻嗪类利尿剂的比较:一项荟萃分析。
J Cell Mol Med. 2017 Nov;21(11):2634-2642. doi: 10.1111/jcmm.13205. Epub 2017 Jun 19.
2
Efficacy of Low-Dose Chlorthalidone and Hydrochlorothiazide as Assessed by 24-h Ambulatory Blood Pressure Monitoring.24 小时动态血压监测评估小剂量氯噻酮和氢氯噻嗪的疗效。
J Am Coll Cardiol. 2016 Feb 2;67(4):379-389. doi: 10.1016/j.jacc.2015.10.083.
3
Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.
在基层医疗中识别假性难治性高血压并优化确诊难治性病例的利尿剂治疗。
Can Pharm J (Ott). 2024 Oct 3;157(6):334-340. doi: 10.1177/17151635241281511. eCollection 2024 Nov-Dec.
4
Synthesis of 1H-isoindolin-1-ones via a simple photodecarboxylative addition of carboxylates to phthalimides and evaluation of their antibiotic activity.通过简单的光脱羧加成反应,将羧酸酯加成到邻苯二甲酰亚胺上合成 1H-异吲哚-1-酮,并评估它们的抗生素活性。
Photochem Photobiol Sci. 2024 Jul;23(7):1353-1360. doi: 10.1007/s43630-024-00600-y. Epub 2024 Jun 18.
5
-Heterocyclic Carbene-Catalyzed Facile Synthesis of Phthalidyl Sulfonohydrazones: Density Functional Theory Mechanistic Insights and Docking Interactions.- 杂环卡宾催化简便合成邻苯二甲酰基磺酰腙:密度泛函理论机理洞察与对接相互作用
ACS Omega. 2024 Feb 26;9(10):11510-11522. doi: 10.1021/acsomega.3c08529. eCollection 2024 Mar 12.
6
Phototoxic Reactions Inducted by Hydrochlorothiazide and Furosemide in Normal Skin Cells-In Vitro Studies on Melanocytes and Fibroblasts.氢氯噻嗪和呋塞米诱导正常皮肤细胞的光毒性反应-黑素细胞和成纤维细胞的体外研究。
Int J Mol Sci. 2024 Jan 24;25(3):1432. doi: 10.3390/ijms25031432.
7
Hyponatremia in patients with arterial hypertension: pathophysiology and management.动脉高血压患者的低钠血症:病理生理学与管理
Arch Med Sci. 2023 Mar 26;19(6):1630-1645. doi: 10.5114/aoms/161578. eCollection 2023.
8
Fluorescent molecularly imprinted polymer nanocomposite for solid-phase extraction and fluorimetric determination of hydrochlorothiazide.用于固相萃取和荧光法测定氢氯噻嗪的荧光分子印迹聚合物纳米复合材料
RSC Adv. 2023 Oct 4;13(41):29051-29060. doi: 10.1039/d3ra04912d. eCollection 2023 Sep 26.
9
Effect of administration of low-dose irbesartan and hydrochlorothiazide combined with levamlodipine at different times on the circadian rhythm of blood pressure and the levels of MMPs and TIMPs in non-dipper patients with grade 1 and 2 hypertension.不同时间给予小剂量厄贝沙坦氢氯噻嗪联合左旋氨氯地平对 1、2 级高血压非杓型患者血压昼夜节律及 MMPs、TIMPs 水平的影响。
J Clin Hypertens (Greenwich). 2023 Feb;25(2):137-145. doi: 10.1111/jch.14630. Epub 2023 Jan 14.
10
Effect of the combination of bumetanide plus chlorthalidone on hypertension and volume overload in patients with chronic kidney disease stage 4-5 KDIGO without renal replacement therapy: a double-blind randomized HEBE-CKD trial.在未接受肾脏替代治疗的 4-5 期慢性肾脏病 KDIGO 患者中,布美他尼联合氯噻酮对高血压和容量超负荷的影响:一项双盲随机 HEBE-CKD 试验。
BMC Nephrol. 2022 Sep 20;23(1):316. doi: 10.1186/s12882-022-02930-4.
氢氯噻嗪与吲达帕胺和氯噻酮的直接比较:降压和代谢作用。
Hypertension. 2015 May;65(5):1041-6. doi: 10.1161/HYPERTENSIONAHA.114.05021. Epub 2015 Mar 2.
4
Risk of hyponatremia with diuretics: chlorthalidone versus hydrochlorothiazide.利尿剂相关低钠血症风险:氯噻酮与氢氯噻嗪。
Am J Med. 2014 Aug;127(8):763-71. doi: 10.1016/j.amjmed.2014.04.014. Epub 2014 May 5.
5
Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study.氯噻酮与氢氯噻嗪治疗老年人高血压:基于人群的队列研究。
Ann Intern Med. 2013 Mar 19;158(6):447-55. doi: 10.7326/0003-4819-158-6-201303190-00004.
6
Comparison of the efficacy between hydrochlorothiazide and chlorthalidone on central aortic pressure when added on to candesartan in treatment-naïve patients of hypertension.比较氢氯噻嗪和氯噻酮在加用坎地沙坦治疗初治高血压患者时对中心动脉压的疗效。
Hypertens Res. 2013 Jan;36(1):79-84. doi: 10.1038/hr.2012.143. Epub 2012 Oct 4.
7
Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.氢氯噻嗪、氯噻酮和苯氟噻嗪对血压、血钾和尿酸的剂量-反应关系的荟萃分析。
Hypertension. 2012 Jun;59(6):1104-9. doi: 10.1161/HYPERTENSIONAHA.111.190637. Epub 2012 Apr 30.
8
Chlorthalidone reduces cardiovascular events compared with hydrochlorothiazide: a retrospective cohort analysis.氯噻酮比氢氯噻嗪更能降低心血管事件:一项回顾性队列分析。
Hypertension. 2011 Apr;57(4):689-94. doi: 10.1161/HYPERTENSIONAHA.110.161505. Epub 2011 Mar 7.
9
Meta-analysis of dose-response characteristics of hydrochlorothiazide and chlorthalidone: effects on systolic blood pressure and potassium.氢氯噻嗪和氯噻酮剂量-反应特征的荟萃分析:对收缩压和钾的影响。
Am J Hypertens. 2010 Apr;23(4):440-6. doi: 10.1038/ajh.2010.1. Epub 2010 Jan 28.
10
A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.一项随机对照研究,评估氯沙坦 - 低剂量氢氯噻嗪(6.25毫克)联合用药与氯沙坦 - 氢氯噻嗪(12.5毫克)联合用药对印度轻至中度原发性高血压患者的疗效和耐受性。
Expert Opin Pharmacother. 2009 Jul;10(10):1529-36. doi: 10.1517/14656560902991514.